Pillstats
Rx only · Solution · Oral

Theophylline

Theophylline Anhydrous

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10438
US makers6 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.032$0.064$0.095$0.127Dec 2025Apr 2026Jul 2026
$0.111
Latest avg · Jul 22, 2026
+6%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

931872803742025 Q12025 Q22025 Q32025 Q42026 Q1
321
Rx · 2026 Q1
227K
Units dispensed
-1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
PAI Holdings, LLC dba PAI Pharmaunknown3SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
ATLANTIC BIOLOGICALS CORP.unknown1SUPPLYING
Cranbury Pharmaceuticals, LLCunknown1SUPPLYING
Chartwell Governmental & Specialty RX, LLC.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.